nitrogenase stabilizing-protective protein, bacteria has been researched along with Prostatic Neoplasms in 16 studies
*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalton, JT; Hwang, DJ; Miller, DD; Mohler, ML; Rakov, IM; Xu, H; Yang, J | 1 |
| Dence, CS; Jenks, C; Katzenellenbogen, JA; Parent, EE; Sharp, TL; Welch, MJ | 1 |
| Brulé, E; Jaouen, G; McGlinchey, MJ; Müller-Bunz, H; Payen, O; Plamont, MA; Top, S; Vessières, A | 1 |
| Hashimoto, Y; Imai, K; Miyachi, H; Tanatani, A; Wakabayashi, K | 1 |
| Endo, Y; Fujii, S; Goto, T; Ohta, K; Ohta, S | 1 |
| Aikawa, K; Baba, A; Hara, T; Hasuoka, A; Ito, M; Kaku, T; Kanzaki, N; Kobayashi, H; Yamamoto, S; Yamaoka, M | 1 |
| Beretta, GL; Carloni, S; Castoria, G; De Cesare, M; Del Rio, A; Di Donato, M; Ferroni, C; Guerrini, A; Leonetti, C; Paganelli, G; Porru, M; Tesei, A; Varchi, G; Zaffaroni, N; Zamagni, A | 1 |
| Fujii, S; Hashimoto, Y; Hirano, T; Inoue, K; Ishigami-Yuasa, M; Kagechika, H; Kanai, M; Kawachi, E; Matsumura, M; Mori, S; Tanatani, A; Urushibara, K; Yura, K | 1 |
| Bassetto, M; Brancale, A; Ferla, S; Kandil, S; McGuigan, C; Pertusati, F; Westwell, AD | 2 |
| Anand, SA; Divakar, S; Elancheran, R; Kabilan, S; Kotoky, J; Lokanath, NK; Ramanathan, M; Saravanan, K | 1 |
| Beretta, GL; Cortesi, M; De Cesare, M; Ferroni, C; Guerrini, A; Kim, YS; Lee, S; Malhotra, SV; Parenti, MD; Pepe, A; Tesei, A; Trepel, JB; Varchi, G; Zaffaroni, N; Zamagni, A | 1 |
| Fujii, S; Ishigami-Yuasa, M; Kagechika, H; Kazui, Y; Tanatani, A; Yamada, A | 1 |
| He, Y; Hwang, DJ; McEwan, IJ; Miller, DD; Mohler, ML; Narayanan, R; Ponnusamy, S; Thiyagarajan, T | 1 |
| Dart, DA; Davies, L; Kandil, S; Lee, KY; Rizzo, SA; Westwell, AD | 1 |
| Bassetto, M; Brancale, A; Ferla, S; Khandil, S; McGuigan, C; Pertusati, F; Westwell, AD | 1 |
16 other study(ies) available for nitrogenase stabilizing-protective protein, bacteria and Prostatic Neoplasms
| Article | Year |
|---|---|
Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemical Phenomena; Chemistry, Physical; Haplorhini; Humans; Isothiocyanates; Ligands; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Receptors, Androgen; Rhodamines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2006 |
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
Topics: Androgen Antagonists; Anilides; Animals; Bromine Radioisotopes; Fluorine Radioisotopes; Isotope Labeling; Ligands; Male; Mice; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Tosyl Compounds | 2007 |
Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
Topics: Androgen Antagonists; Anilides; Binding, Competitive; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ferrous Compounds; Humans; Hydantoins; Imidazolidines; Male; Models, Molecular; Molecular Structure; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Tosyl Compounds; Tumor Cells, Cultured | 2008 |
4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Cell Line, Tumor; Humans; Male; Mutation; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Pyrroles; Receptors, Androgen | 2008 |
Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Boranes; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen | 2010 |
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Castration; Cell Line, Tumor; Drug Design; Humans; Male; Mice; Models, Molecular; Prostate; Prostatic Neoplasms; Pyrrolidines; Receptors, Androgen; Xenograft Model Antitumor Assays | 2013 |
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides.
Topics: Active Transport, Cell Nucleus; Androgen Receptor Antagonists; Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Models, Chemical; Models, Molecular; Molecular Structure; Mutation; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Xenograft Model Antitumor Assays | 2014 |
Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Mice; Models, Molecular; Molecular Structure; Phthalazines; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2015 |
Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.
Topics: Anilides; Antineoplastic Agents; Benzamides; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Drug Resistance, Neoplasm; Humans; Male; Microsomes, Liver; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitriles; Permeability; Phenylthiohydantoin; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Tosyl Compounds | 2016 |
Rational design and synthesis of novel anti-prostate cancer agents bearing a 3,5-bis-trifluoromethylphenyl moiety.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Molecular Docking Simulation; Molecular Structure; Prostatic Neoplasms; Structure-Activity Relationship; Xylenes | 2016 |
Design, synthesis and biological evaluation of 2-(4-phenylthiazol-2-yl) isoindoline-1,3-dione derivatives as anti-prostate cancer agents.
Topics: Antineoplastic Agents; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Male; Prostatic Neoplasms | 2017 |
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment.
Topics: Animals; Cell Line, Tumor; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Models, Molecular; Nonsteroidal Anti-Androgens; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Triazoles | 2017 |
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Phenols; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2018 |
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.
Topics: Amides; Androgen Receptor Antagonists; Androgens; Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Resistance, Neoplasm; Humans; Indoles; Male; Mice; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Proteolysis; Rats; Receptors, Androgen; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2019 |
Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonists.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Models, Molecular; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2019 |
A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF
Topics: Anilides; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ether-A-Go-Go Potassium Channels; Humans; Hydrocarbons, Fluorinated; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Structure-Activity Relationship; Sulfhydryl Compounds; Tosyl Compounds | 2019 |